万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://fn.bmj.com/
3、投稿网址：https://mc.manuscriptcentral.com/adc
4、期刊刊期：双月刊，逢单月出版。
2021年6月30日星期三
投稿须知【官网信息】
For authors
Editorial policy
Archives of Disease in Childhood: Fetal & Neonatal adheres to the highest standards concerning its editorial policies on publication ethics, scientific misconduct, consent and peer review criteria. The journal follows guidance produced by bodies that include the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME) and the International Committee of Medical Journal Editors (ICMJE).To view all BMJ Journal policies please refer to the BMJ Author Hub policies page.
We take seriously all possible misconduct. If an Editor, author or reader has concerns that a submitted article describes something that might be considered to constitute misconduct in research, publication or professional behaviour they should forward their concerns to the journal. The publisher will deal with allegations appropriately.
Plan S compliance
Archives of Disease in Childhood: Fetal & Neonatal is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
Copyright and authors’ rights
Articles are published under an exclusive licence or non-exclusive licence for UK Crown employees or where BMJ has agreed CC BY applies. For US Federal Government officers or employees acting as part of their official duties, the terms are as stated in accordance with our licence terms. Authors or their employers retain copyright. Open access articles can be reused under the terms of the relevant Creative Commons licence to facilitate reuse of the content; please refer to the Archives of Disease in Childhood: Fetal & Neonatal Author Licence for the applicable Creative Commons licences. More information on copyright and authors’ rights.
When publishing in ADC: Fetal & Neonatal, authors choose between three licence types – exclusive licence granted to BMJ, CC-BY-NC and CC-BY (Creative Commons open access licences require payment of an article processing charge). As an author you may wish to post your article in an institutional or subject repository, or on a scientific social sharing network. You may also link your published article to your preprint (if applicable). What you can do with your article, without seeking permission, depends on the licence you have chosen and the version of your article. Please refer to the BMJ author self archiving and permissions policies page for more information.
Preprints
Preprints foster openness, accessibility and collaboration by allowing authors to make their findings immediately available to the research community and receive feedback on an article before it is submitted to a journal for formal publication.
BMJ fully supports and encourages the archiving of preprints in any recognised, not-for-profit server such as medRxiv. BMJ does not consider the posting of an article in a dedicated preprint repository to be prior publication.
Preprints are reports of work that have not been peer-reviewed; Preprints should therefore not be used to guide clinical practice, health-related behaviour or health policy. For more information, please refer to our Preprint policy page.
Peer review process
Articles submitted to Archives of Disease in Childhood: Fetal & Neonatal are subject to peer review. The journal operates single blind peer review whereby the names of the reviewers are hidden from the author. Manuscripts authored by a member of a journal’s editorial team are independently peer reviewed; an editor will have no input or influence on the peer review process or publication decision for their own article. For more information on what to expect during the peer review process please refer to BMJ Author Hub – the peer review process.
BMJ requests that all reviewers adhere to a set of basic principles and standards during the peer-review process in research publication; these are based on the COPE Ethical Guidelines for Peer Reviewers. Please refer to our peer review terms and conditions policy page.
BMJ is committed to transparency. Every article we publish includes a description of its provenance (commissioned or not commissioned) and whether it was internally or externally peer reviewed.
Plagiarism is the appropriation of the language, ideas or thoughts of another without crediting their true source and representation of them as one’s own original work. BMJ is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. BMJ runs manuscripts through iThenticate during the peer review process. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting www.ithenticate.com.
Manuscript transfer
BMJ and the Royal College of Paediatrics and Child Health have a facility for transferring manuscripts among their paediatric journals. Authors submitting to the flagship journal Archives of Disease in Childhood can choose BMJ Paediatrics Open as an ‘alternate journal’.
Once authors agree for their manuscript to be transferred to another BMJ journal, all versions of the manuscript, any supplementary files and peer review comments will automatically be transferred on the author’s behalf. Please note that there is no guarantee of acceptance. Contact the editorial team for more information or assistance.
Article processing charges
During submission, authors can choose to have their article published open access for 2300 GBP (exclusive of VAT for UK and EU authors). Publishing open access has multiple benefits including wider reach, faster impact and increased citation and usage. There are no submission, page or colour figure charges.
Find out if you are eligible for institutional funding
A number of institutions have open access agreements with BMJ which can either cover the whole cost of open access publishing for authors at participating institutions or can allow authors to receive a discount off the APC.
Visit BMJ’s open access agreements page to find out whether your institution is a member and what discounts you may be entitled to.
For more information on publishing open access with BMJ visit our Author Hub.
Data sharing
Archives of Disease in Childhood: Fetal & Neonatal adheres to BMJ’s Tier 3 data policy. We strongly encourage that data generated by your research that supports your article be made available as soon as possible, wherever legally and ethically possible. All research articles must contain a Data Availability Statement. For more information and FAQs, please see BMJ’s full Data Sharing Policy page.
ORCID
Archives of Disease in Childhood: Fetal & Neonatal mandates ORCID iDs for the submitting author at the time of article submission; co-authors and reviewers are strongly encouraged to also connect their ScholarOne accounts to ORCID. We strongly believe that the increased use and integration of ORCID iDs will be beneficial for the whole research community.
Please find more information about ORCID and BMJ’s policy on our Author Hub.
Paediatric and Perinatal Drug Therapy
Articles for the Paediatric and Perinatal Drug Therapy section should follow the same submission guidelines as the relevant article type, ie, if you are submitting a full original report for the PPDT section it should adhere to the “Original reports” instructions as outlined below.
Rapid responses
A rapid response is a moderated but not peer reviewed online response to a published article in ADC Fetal & Neonatal; it will not receive a DOI and will not be indexed. Find out more about responses and how to submit a response.
Submission guidelines
Please review the below article type specifications including the required article lengths, illustrations, table limits and reference counts. The word count excludes the title page, abstract, tables, acknowledgements, contributions and references. Manuscripts should be as succinct as possible.
For further support when making your submission please refer to the resources available on the BMJ Author Hub. Here you will find information on writing and formatting your research through to the peer review process and promoting your paper. You may also wish to use the language editing and translation services provided by BMJ Author Services.
If your article is accepted you can take advantage of BMJ’s partnership with Kudos, a free service to help you maximise your article’s reach.
Original research
Short reports
Letter
Archimedes
Images in neonatal medicine
Editorial
Viewpoint
Review
Supplement
Original research
These should report original research. (max 2500 words, excluding abstract, tables and figures and references). The body of the report should be double spaced. The tables should be single spaced and the tables and figures should be at the end of the submission after the references. Please note that all RCT must be appropriately registered and this should be noted on the cover page.
Title
The title should have no more than 10 words. If relevant, the title should include information as to whether the paper is a randomised control trial, meta-analysis, audit, observational study, etc.
Abstract
The abstract of an experimental or observational study must clearly state in sequence and in not more than 250 words (i) the main purpose of the study, (ii) the essential elements of the design of the study, (iii) the most important results illustrated by numerical data but not p values, and (iv) the implications and relevance of the results.
We require a structured abstract of up to 250 words for reports of randomised controlled trials and meta-analyses, and we encourage it for other studies, where appropriate. The following headings should be used for original research:
Objective
Design
Setting
Patients
Interventions
Main outcome measures
Results: give numerical data rather than vague statements that drug x produced a better response than drug y. Favour confidence intervals over p values, and give the numerical data on which any p value is based.
Conclusions: do not make any claims that are not supported by data in the paper in the abstract.
Important considerations
All research reports involving human subjects must contain a statement about ethics committee approval (or equivalent) at the end of the methods section.
On a separate page (before the references) all original papers should include:
“What is already known on this topic” – followed by a maximum of 3 brief statements (no more than 25 words per statement);
“What this study adds” – followed by a maximum of 3 brief statements (no more than 25 words per statement).
Illustrations should be used only when data cannot be expressed clearly in any other way. When graphs are submitted the numerical data on which they are based should be uploaded to ScholarOne as a supplementary file.
It is a journal requirement that the EQUATOR checklist relevant to the study is supplied. Research checklists should be uploaded during the submission process; if these are not applicable to your research please state the reason in your cover letter.
Further details of RCTs and systematic reviews.
Qualitative research should use the COREQ checklist.
Word count: up to 2500 words (excluding title page, abstract, tables, figures, and references)
Structured abstract: up to 250 words
Tables/Illustrations: up to 5
References: up to 40
Additional material may be considered as data supplements.
……
更多详情：
https://fn.bmj.com/pages/authors/
